Author

J. W. Li

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell signaling & trafficking· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:development & morphogenesis· 1

Frequent Co-Authors

J. Lu· 2 shared L. Wu· 2 shared A. Bryant· 1 shared A. Shenoy· 1 shared F. J. DeMayo· 1 shared F. J. Kaye· 1 shared H. Chen· 1 shared H. Luo· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

J. Lu

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Crosstalk between paralogous ComRS quorum-sensing systems diversifies the competence/bacteriocin networks of oral streptococci

J. W. Li, R. M. Wyllie, P. Jensen

The paper shows that paralogous ComRS quorum-sensing systems in oral streptococci diversify competence and bacteriocin networks through crosstalk and sequence specificity.

bioRxiv · Oct 14, 2022 · PreprintMicrobiology

FBXO11 deficiency in mice impairs lung development and aggravates cigarette smoke-induced airway fibrosis

J. Lu, A. Shenoy, H. Luo, S. Lulu, J. W. Li, Y. Jin, Q. Yu, S. Guo, V. Shenoy, H. Chen, A. Bryant, L. Wu, J. Chang, K. Mohammed

This study shows that FBXO11 deficiency in mice leads to impaired lung development and worsens cigarette smoke-induced airway fibrosis by promoting epithelial-mesenchymal transition.

bioRxiv · May 31, 2022 · PreprintCell Biology

Dependency of LKB1-inactivated lung cancer on aberrant CRTC-CREB activation

X. Zhou, J. W. Li, Z. Chen, W. Ni, X. Li, R. Yang, H. Shen, J. Liu, F. J. DeMayo, J. Lu, F. J. Kaye, L. Wu

This study shows that CRTC-CREB activation drives LKB1-null lung cancer growth and identifies it as a therapeutic target.

bioRxiv · Jan 9, 2021Cancer Biology